Affiliation:
1. Department of Cardiovascular/Metabolic Disease Schering-Plough Research Institute
Publisher
Japan Atherosclerosis Society
Subject
Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine
Reference46 articles.
1. 1) van Heek M, France C, Compton DS, Mcleod RL, Yumibe NP, Alton KB, Sybertz EJ, and Davis HR: In-vivo mechanism-based discovery of a potent cholesterol absorption inhibitor (SCH58235) through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther, 1997; 283: 157-163
2. 2) Clader J: The discovery of ezetimibe: A view from outside the receptor. J Med Chem, 2004; 47: 1-9
3. 3) van Heek M, France C, Compton D, Hoos L, Alton K, Sybertz E, and Davis HR: Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacology, 2000; 129: 1748-1754
4. 4) van Heek M, Compton DS, and Davis HR: The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. European J Pharm, 2001; 415: 79-84
5. 5) van Heek M, Farley C, Compton DS, Hoos L, and Davis HR: Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. British J Pharm, 2001; 134: 409-417
Cited by
144 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献